Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  Sinopharm Group Co., Ltd.    1099   CNE100000FN7

SINOPHARM GROUP CO., LTD.

(1099)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sinopharm : Nine-Month Net Profit Rose 12%

share with twitter share with LinkedIn share with facebook
share via e-mail
10/27/2019 | 07:56pm EDT

By Martin Mou

Sinopharm Group Co.'s (1099.HK) net profit for the first nine months of the year rose 12% on year as operating revenue increased.

Net profit was 4.60 billion yuan ($651.0 million), compared with CNY4.12 billion a year earlier, Sinopharm Group said Monday.

Revenue increased to CNY312.69 billion from CNY250.82 billion, said the Chinese company, which mainly engages in the distribution of pharmaceutical and healthcare products.

Write to Martin Mou at martin.mou@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
SINOPHARM GROUP CO., LTD. 2.72% 20.05 End-of-day quote.-29.53%
UNITED STATES DOLLAR (B) / CHINESE YUAN IN HONG KONG (USD/CNH) -0.12% 7.1063 Delayed Quote.2.14%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SINOPHARM GROUP CO., LTD.
05/27Geopolitical Power Play Over Coronavirus Vaccine Leaves Drugmakers in the Mid..
DJ
04/23Italy's Triboo starts selling Chinese COVID-19 antibody tests
RE
04/21SINOPHARM GROUP CO., LTD. : quaterly earnings release
02/24China, Hong Kong stocks drop as coronavirus fears deepen
RE
01/16Sinopharm to Raise HK$4 Billion via Sale of H Shares
DJ
2019China stocks rise on Trump's remarks on trade talks; Hang Seng gains
RE
2019SINOPHARM : Nine-Month Net Profit Rose 12%
DJ
2019SINOPHARM : Announcement
PU
2019SINOPHARM : Announcement principal financial data of cnmdc for the nine months e..
PU
2019SINOPHARM : Announcement principal financial data of sinopharm (cncm ltd) for th..
PU
More news
Financials
Sales 2020 464 B 65 216 M 65 216 M
Net income 2020 6 591 M 927 M 927 M
Net Debt 2020 14 997 M 2 110 M 2 110 M
P/E ratio 2020 9,16x
Yield 2020 3,21%
Capitalization 62 529 M 8 068 M 8 797 M
EV / Sales 2019
EV / Sales 2020 0,17x
Nbr of Employees 93 764
Free-Float 40,1%
Chart SINOPHARM GROUP CO., LTD.
Duration : Period :
Sinopharm Group Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOPHARM GROUP CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 24,87 CNY
Last Close Price 20,05 CNY
Spread / Highest target 89,5%
Spread / Average Target 24,0%
Spread / Lowest Target -29,0%
EPS Revisions
Managers
NameTitle
Yong Liu President & Executive Director
Fang Yao Chairman-Supervisory Board
Zhi Ming Li Chairman
Xiu Chang Jiang Chief Financial Officer & Vice President
Jin Dong Deng Non-Executive Director
Sector and Competitors